The excerpt below, from the National Institutes of Health (http://www.nhlbi.nih.gov/
“In recent years, short-term survival after lung transplant has improved. Recent data on single-lung transplants show that:
About 78 percent of patients survive the first year
About 63 percent of patients survive 3 years
About 51 percent of patients survive 5 years
Survival rates for double-lung transplants are slightly better. Recent data show that the median survival for single-lung recipients is 4.6 years. The median survival for double-lung recipients is 6.6 years. Talk with your doctor about what these figures may mean for you.”
As you can see, the median number of years added to a person’s life post lung transplant ranges from 4.6 years to 6.6 years depending on the type of surgery received. This procedure can improve quality of life, but there is also risk of complications including infection, rejection of the new lung(s), and in some cases, an increased chance of developing diabetes, kidney damage, and osteoporosis.
Regenerative therapies are emerging as an alternative and preemptive treatment, to the invasive option of lung transplantation.
How do stem cells restore damaged lung tissue?
Lung Institute utilizes autologous stem cells, meaning those derived from the patient’s own blood or fat tissue, for treatment. These somatic, or adult, stem cells have the unique ability to self-renew and replicate, and are capable of forming any type of tissue found in the human body, including lung tissue.
What is the stem cell treatment process like?
This minimally invasive, outpatient procedure is performed over the course of three days within our office located in downtown Tampa, FL. For pulmonary conditions, the stem cells are stimulated to increase in number by oral and injectable agents. Next, the stem cells are derived from the patient’s own blood or bone marrow and are given back to the patient intravenously. The patient will receive agents by nebulizer and by injection that have been shown to repair and regenerate lung tissue.
In conclusion: Stem Cell Therapy vs. Lung Transplant for Lung Disease
Both stem cell therapies and lung transplantation have been proven, in many cases, to improve sufferer’s quality of life. However, lung transplantation is an invasive, inpatient surgery that can have risky complications and a longer recovery time.
Stem cell therapies do not replace the need for a lung transplant, but can slow the progression of lung disease, and therefore prolong the need for a transplant. Stem cells and other forms of regenerative therapies are also proven to significantly improve sufferer’s quality of life.
A recent Lung Institute patient, Peter Pike, was diagnosed with COPD and underwent stem cell therapies with at our clinic in Tampa a little over 5 months ago. He is now able to perform everyday functions without feeling out of breath; even his wife says his overall disposition has improved. To learn more about how Pike’s life has improved, watch his testimonial video by clicking here (http://lunginstitute.com/
To learn more about lung disease research in the field of regenerative medicine, visit our research archive by clicking here.
813 503 8698
813 503 8698